Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

26.66
Delayed Data
As of Sep 04
 +0.04 / +0.15%
Today’s Change
13.47
Today|||52-Week Range
33.74
+65.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues51.5M194.6M32.2M94.5M
 
 
 
 
 
Cost of Goods Sold3.1M2.8M2.7M22.3M
 
 
 
 
 
Depreciation And Amortization3.0M3.0M3.0M27.3M
 
 
 
 
 
 
Operating ExpensesGross Income45.4M188.8M26.6M44.9M
 
 
 
 
 
General Expenses28.7M31.0M37.9M53.9M
 
 
 
 
 
Research And Development1.6M2.0M1.9M4.7M
 
 
 
 
 
Total Operating Expenses34.8M36.8M43.6M103.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income16.7M157.8M-11.4M-9.0M
 
 
 
 
 
Extraordinary Credit----1.8M1.3M
 
 
 
Extraordinary Charge-4.9M---686.0K-10.2M
 
 
 
 
Interest Expense On Debt1.4M6.1M5.6M21.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income10.4M151.8M-15.8M-39.2M
 
 
 
 
 
Income Taxes-4.0M-57.2M-4.2M-17.6M
 
 
 
 
 
Net Income6.5M94.6M-11.6M-21.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS58.6M58.9M59.6M60.0M
 
 
 
 
 
Shares To Calculate EPS Diluted60.9M79.4M59.6M60.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.11$1.23-$0.20-$0.36
 
 
 
 
 
EPS Diluted$0.11$1.23-$0.20-$0.36